Health Care Sector Update for 06/14/2019: ARQL, NAVB, MCRB, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks:
Major health care stocks were mostly flat pre-bell Friday.
Stocks moving on news include:
(+) ArQule (ARQL), which was surging by more than 45% as preliminary data from a phase 1 study for ARQ 531, an inhibitor of wild type and C481S-mutant Bruton's tyrosine kinase (BTK) in patients with relapsed or refractory hematologic malignancies show "compelling clinical activity at a well-tolerated dose in patients who have already exhausted available therapies."
(-) Navidea Biopharmaceuticals (NAVB), was slumping more than 28% after it priced an underwritten public offering of 8 million shares at $0.75 per share.
(-) Seres Therapeutics (MCRB) was retreating more than 24% after it priced an underwritten public offering of 26,666,667 shares at $2.25 each. The offering is expected to close on or about June 18.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.